The EU Probe Into Pharmaceutical Patent Settlements

Law360, New York (April 27, 2010, 12:59 PM EDT) -- Acting on the basis of its findings in a pharmaceutical sector inquiry instituted in January 2000, the European Commission recently launched investigations into patent settlements between originator and generic pharmaceutical companies.

Specifically, on Jan. 12, 2010, the Commission issued requests for information to a number of pharmaceutical companies seeking copies of their patent settlement agreements that related to the EU and were concluded between originator and generic pharmaceutical companies from July 1, 2008 to Dec. 31, 2009. (See Commission IP/10/12)

In particular, the Commission is seeking...
To view the full article, register now.